Guardant Health
GH
#1740
Rank
ยฃ8.66 B
Marketcap
ยฃ66.04
Share price
1.76%
Change (1 day)
85.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of December 2025 : ยฃ1.28 Billion

According to Guardant Health 's latest financial reports the company's total debt is ยฃ1.28 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2025-12-31ยฃ1.26 B19.27%
2024-12-31ยฃ1.06 B0.19%
2023-12-31ยฃ1.06 B-6.12%
2022-12-31ยฃ1.13 B11.21%
2021-12-31ยฃ1.01 B62.34%
2020-12-31ยฃ0.62 B1934.95%
2019-12-31ยฃ30.8 M
2018-12-31N/A-100%
2017-12-31ยฃ0.48 M-96.47%
2016-12-31ยฃ13.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Neogen
NEOG
ยฃ0.59 B-53.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
ยฃ0.16 B-87.46%๐Ÿ‡บ๐Ÿ‡ธ USA